The fiducial markers market is expanding due to increasing adoption of image-guided radiotherapy and precision oncology. These markers enhance treatment accuracy by helping target tumors during radiation therapy. Rising cancer incidence worldwide is a major growth driver. Advancements in imaging technologies and minimally invasive procedures are further supporting demand. https://www.databridgemarketresearch.com/reports/global-fiducial-markers-market